Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Colorectal Cancer Clinical Trials in Maryland | 330 Studies

Clinical Trials Colorectal CancerMaryland

Colorectal Cancer Clinical Trials in Maryland

Find 330 clinical trials for colorectal cancer near Maryland. Connect with research centers in your area.

All Colorectal Cancer trials nationwide All trials in Maryland

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 21-40 of 330 trials

RecruitingFamily Communications After Genetic TestingThis clinical trial compares patient (proband)-mediated communication to provider-mediated communication for improving genetic testing in first-degree relatives of patients with…NCT07143487·Birmingham, Alabama and 364 others

Colorectal Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingA Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal CancerThe purpose of this study is to evaluate the efficacy and safety of standard-of-care chemotherapy and bevacizumab with or without INCA33890 in the first-line treatment of…NCT07284849·Mobile, Alabama and 296 others

CompletedPembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid TumorsThis is an open-label, multicenter, Phase 1b platform study in subjects with advanced or metastatic solid tumors (Part 1a) and subjects with selected solid tumors (Part 1b and…NCT02646748·San Francisco, California and 16 others

RecruitingA Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid MalignanciesThe purpose of this study is to evaluate the safety, tolerability, and efficacy of BMS-986523 alone and in combination with anti-cancer agents in participants with advanced solid…NCT07223047·Baltimore, Maryland and 7 others

TerminatedCombination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00006015·Birmingham, Alabama and 46 others

Active not recruitingA Study of Novel Study Interventions and Combinations in Participants With Colorectal CancerThe main purpose of this study is to evaluate the safety and efficacy of novel study interventions and combinations in participants with Colorectal Cancer (CRC).NCT06792695·Scottsdale, Arizona and 55 others

CompletedA Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal CancerTo see how well enzastaurin in combination with irinotecan and cetuximab works versus irinotecan and cetuximab in participants who have progressed within 3 months.NCT00437268·Casa Grande, Arizona and 19 others

CompletedSample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)The primary objective of this study is to gather stool samples from subjects with inflammatory bowel disease (IBD) to be added to a test set of stool samples that will be utilized…NCT02503696·Dothan, Alabama and 28 others

Active not recruitingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCThis is a First-in-Human Phase IA/IB/II open label dose escalation study of intravenous (IV) administration of ONC-392, a humanized anti-CTLA4 IgG1 monoclonal antibody, as single…NCT04140526·Springdale, Arkansas and 36 others

CompletedStudy of Colon GVAX and Cyclophosphamide in Patients With Metastatic Colorectal CancerThe primary objective of this study is to evaluate the safety and feasibility of vaccination with two irradiated allogeneic colorectal carcinoma cells administered with a GM-CSF…NCT00656123·Baltimore, Maryland

TerminatedContinuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary MetastasesBackground: Mithramycin is a new cancer drug. In another study, people with chest cancer took the drug 6 hours a day for 7 straight days.NCT02859415·Bethesda, Maryland

CompletedSelumetinib and Cetuximab in Treating Patients With Refractory Solid TumorsThis phase I trial is studying the side effects and the best dose of MEK Inhibitor AZD6244 when given together with cetuximab in patients with advanced or refractory solid tumors…NCT01217450·Bethesda, Maryland and 2 others

TerminatedA Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid TumorsThis research study is studying a new drug, NC410, as a possible treatment for advanced or metastatic solid tumors.NCT04408599·Bethesda, Maryland and 4 others

TerminatedAdministering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12D Variant of Mutated RAS in HLA-A*11:01 PatientsBackground: A new cancer therapy takes white blood cells from a person, grows them in a lab, genetically changes them, then gives them back to the person.NCT03745326·Bethesda, Maryland

CompletedDetection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel DiseaseThis study aims to determine the performance of the Exact IBD-ACRN surveillance test to detect colorectal cancer (CRC) and colorectal neoplasia in patients with inflammatory bowel…NCT01819766·Phoenix, Arizona and 25 others

RecruitingStudy of RMC-9805 in Participants With KRAS G12D-Mutant Solid TumorsThis study is to evaluate the safety and tolerability of RMC-9805 as monotherapy and in combination with RMC-6236 in adults with KRAS G12D-mutant solid tumors.NCT06040541·Sacramento, California and 16 others

CompletedMK-2206 and AZD6244 in Patients With Advanced Colorectal CarcinomaBackground: \- MK-2206 and AZD6244 (Selumetinib) are experimental cancer treatment drugs that block the effect of certain proteins that cancer cells need to grow and survive.NCT01333475·Bethesda, Maryland

CompletedA Study Combining FOLFOX or FOLFIRI With AG-013736 or Bevacizumab (Avastin) in Patients With Metastatic Colorectal Cancer After Failure Of One First Line RegimenThe study is designed to demonstrate that the combination of AG-013736 with either FOLFIRI or FOLFOX is superior to FOLFIRI or FOLFOX in combination with bevacizumab (Avastin) in…NCT00615056·Mobile, Alabama and 82 others

CompletedAzacitidine and Entinostat in Treating Patients With Metastatic Colorectal CancerThis phase II trial is studying how well giving azacitidine together with entinostat works in treating patients with metastatic colorectal cancer.NCT01105377·Scottsdale, Arizona and 13 others

RecruitingA Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)The NSABP FC-13 study is being done to determine if using immunotherapies alone or in combination with other drugs will delay or prevent colorectal cancer from coming back in…NCT07058012·Gainesville, Florida and 12 others

PreviousPage 2 of 17Next

Other Conditions in Maryland

Breast Cancer Lung Cancer Prostate Cancer Melanoma Leukemia Lymphoma